-
Magnesium sulfate indications
decrease seizures with eclampsia; tocolytic
-
Magnesium sulfate contraindications
HTN, vaginal bleeding, cardiac disease
-
Magnesium sulfate adverse reactions
keep calcium gluconate around; hypocalcemia; low RR, SOA; headache
-
Oxytocin indications
contraction of the uterus, decreases bleeding, used in induction of labor
-
Oxytocin contraincidations
None
-
Oxytocin adverse reactions
infrequent water intoxication, nausea, vomiting, placental abruption, uterine rupture, PPH, infection
-
Terbutaline indications
relaxes smooth muscle inhibiting uterine activity and causing bronchodilation
-
Terbutaline contraindications
women with cardiac disease, DM, HTN, eclampsia, migraines, hyperthyroidism, significant hemorrhage
-
Terbutaline adverse reactions
tachycardia, dizziness, nervousness, headache, nasal congestion, nausea and vomiting, hypokalemia, hyperglycemia, hypotension; bad if HR>130, BP<90/60
-
Methergine indications
contraction of uterus (decreases bleeding)
-
Methergine contraindications
HTN, cardiac disease
-
Methergine adverse reactions
HTN, nausea, vomiting, headache
-
Steroids
stimulate fetal lung maturity
-
Non stress test reactive
2 accelerations in a 20 minute period each lasting at least 15 seconds and peaking at least 15 BPM above the baseline (before 32 weeks of gestation, alleleration is an increase of at least 10 BPM and leasting at least 10 seconds)
-
Non stress test nonreactive
does not produce two or more qualifying accelerations in a 20 minute period
-
Stress test
negative (no late decelerations-desired result)
-
Positive stress test
IUFD, late FHR decels in labor, IUGR and meconium stained amniotic fluid
-
Positive stress test interpretation
late decels occur with 50% or more of contractions
-
-
Variable decelerations interventions
reposition, administer O2 by nonrebreather face mask, assess for prolapsed cord, notify physician
-
Late deceleration interventions
reposition/elevate legs, increase rate of IV/bolus, DC oxytocin, administer O2, notify dr, amnioinfusion, tocolytic therapy
-
Assessment for uterine inversion
hemorrhage, shock, pain in absence of a palpable fundus abdominally; complete-large rounded mass outside uterus; incomplete-a smooth mass palpated through the dilated cervix
|
|